U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 21 to 40 of 105

Tests names and labsConditionsGenes, analytes, and microbesMethods

Comprehensive Myeloid Profile + CALR PCR + FLT3 PCR

PathGroup
United States
1665
  • T Targeted variant analysis

Invitae Monogenic Obesity Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
9268
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hematological Malignancy Fusion Panel

Laboratory for Molecular Pediatric Pathology Boston Children's Hospital
United States
871
  • R RNA analysis

Invitae Overgrowth Syndromes Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
9653
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Autism Spectrum Disorders (ASD) Panel

PreventionGenetics, part of Exact Sciences
United States
224170
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

GTC-Solid Tumor Profile Plus Fusion/Expression (DNA and RNA)

Genomic Testing Cooperative, LCA
United States
1434
  • R RNA analysis
  • C Sequence analysis of the entire coding region

GTC-Solid Tumor Profile

Genomic Testing Cooperative, LCA
United States
1434
  • C Sequence analysis of the entire coding region

FusionPlex Pan-Heme Panel

Clinical Genomics Laboratory Laboratory for Precision Diagnostics, University of Washington
United States
649
  • R RNA analysis

Luscan-Lumish syndrome, 616831, Autosomal dominant (SETD2 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Luscan-Lumish syndrome, 616831, Autosomal dominant (SETD2 gene) (Sequence Analysis-All Coding Exons) (Prenatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

SmartGenomics GYN Profile with Microsatellite Instability Analysis

PathGroup
United States
652
  • I Microsatellite instability testing (MSI)
  • T Targeted variant analysis

Comprehensive HemeComplete Profile with IGH Somatic Hypermutation

PathGroup
United States
13161
  • E Sequence analysis of select exons
  • T Targeted variant analysis

HemeComplete NextGen Sequencing Assay with Calreticulin Exon 9 Mutation, FLT3 ITD and TKD Analysis and T-Cell Clonality Analysis

PathGroup
United States
23160
  • T Targeted variant analysis

HemeComplete NextGen Sequencing Assay with Calreticulin Exon 9 Mutation, FLT3 ITD and TKD Analysis and JAK2 V617F Quant

PathGroup
United States
18160
  • T Targeted variant analysis

Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR + BCR/ABL1 IS

PathGroup
United States
17160
  • T Targeted variant analysis

Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR + BCR/ABL1

PathGroup
United States
17160
  • T Targeted variant analysis

Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR

PathGroup
United States
16160
  • T Targeted variant analysis

qGenEx Intellectual disability

Quantitative Genomic Medicine Laboratories, SL
Spain
31969
  • S Mutation scanning of the entire coding region
  • C Sequence analysis of the entire coding region

Genomic Unity Epilepsy Analysis (includes STR analysis of 6 loci)

Variantyx, Inc.
United States
1378
  • D Deletion/duplication analysis
  • X Mutation scanning of select exons
  • C Sequence analysis of the entire coding region

Overgrowth and Macrocephaly Syndromes Panel

PreventionGenetics, part of Exact Sciences
United States
145112
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Results: 21 to 40 of 105

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.